Edition:
United States

Medistim ASA (MEDS.OL)

MEDS.OL on Oslo Stock Exchange

73.50NOK
20 Jan 2017
Change (% chg)

kr0.50 (+0.68%)
Prev Close
kr73.00
Open
kr73.00
Day's High
kr73.50
Day's Low
kr73.00
Volume
831,162
Avg. Vol
43,591
52-wk High
kr84.00
52-wk Low
kr44.00

Summary

Name Age Since Current Position

Oyvin Broymer

68 2000 Chairman of the Board

Kari Krogstad

52 2009 President, Chief Executive Officer

Bjorn Wiggen

57 Deputy Chairman of the Board

Thomas Jakobsen

2001 Chief Financial Officer

Mike Farbelow

2014 President of Medistim USA, Inc.

Ole Robsrud

Managing Director Medistim Norge AS

Roger Morberg

2010 Vice President Sales

Haege Krogh Wetterhus

Vice President Marketing

Anders Lillebo

2004 Vice President Manufacturing

Tone Veiteberg

Vice President Regulatory Affairs & Quality Assurance

Erik Swensen

2002 Vice President Research and Development

Siri Furst

58 2013 Director

Tove Raanes

39 2014 Director

Lars Ronn

52 Director

Biographies

Name Description

Oyvin Broymer

Mr. Oyvin A. Broymer has served as Chairman of the Board of Directors of Medistim ASA since 2000. He works as Consultant and Investor through his own company. He previously served as Chief Financial Officer and Executive Vice President of the Aker Group, Hafslund Nycomed ASA between 1980 and 1996, and Executive Vice President of Leif Hoeg & Co ASA between 1996 and 2000. He has experience in the medical industry. Mr. Broymer holds a Master’s degree from University of Wisconsin and a degree in Economics and Business from Handelshoyskolen BI.

Kari Krogstad

Ms. Kari Eian Krogstad has been President and Chief Executive Officer of Medistim ASA since September 1, 2009. Krogstad holds a M.Sc. degree in Molecular Biology from the University of Oslo as well as a Business degree from IHM Business School. She has 20 years of experience from the biomedical industry, from commercial roles within the pharma, biotech and medtech sectors. Krogstad has held senior leadership positions within marketing, sales, business development and general management in Nycomed and Dynal. Before joining Medistim, she spent 11 years at Dynal, where she led Invitrogen Dynal in the role as General Manager after the acquisition from Invitrogen in 2005.

Bjorn Wiggen

Mr. Bjorn M. Wiggen serves as Deputy Chairman of the Board at MEDISTIM ASA. He has been Director of the Company since April 23, 2014. He holds an MBA, and has a broad background and experience from Norwegian industry, particularly within food, media and branding. He has been Managing Director of Orkla ASA, and is currently Executive Chairman of Salvesen and Thams Invest AS, where he is the biggest shareholder.

Thomas Jakobsen

Mr. Thomas Kure Jakobsen has served as Chief Financial Officer at Medistim ASA since 2001. His previous experience includes Controller and Finance Manager at Sysdeco (1993-1998), and Finance Director of Microtronica Nordic (1998-2001), where he was responsible for building the finance team and converting to a new MIS system. Thomas has a key role in the finance and business development of Medistim. Thomas holds a B.Sc. in Management from the Norwegian School of Management.

Mike Farbelow

Mr. Mike Farbelow has been President of Medistim USA, Inc. within Medistim ASA since September 18, 2014. He has previously been Acting President of Medistim USA, Inc. within Medistim ASA since January 7, 2014. Mike Farbelow joined Medistim in May 2012 as Vice President of US sales team. Mr. Farbelow has experience selling surgical devices and managing sales teams in the medical device market. He served for many years with Smith & Nephew’s Endoscopy division both as a sales representative and the Director of Sales for the central region. His most recent position prior to joining Medistim was with Richard Wolf USA where he served as their national sales manager in spinal endoscopy. He holds a degree in management from the University of Minnesota Carlson School of Management.

Ole Robsrud

Mr. Ole Jorgen Robsrud serves as Managing Director Medistim Norge AS within Medistim ASA. Ole Jorgen comes from the position as Country Manager in HemoCue Norway, a company that sells diagnostic analysis equipment for the health sector. He also has 13 years of experience in the pharmaceutical company Pfizer, where he has held a variety of management positions in sales and marketing both on national and international level. Ole Jorgen holds a Master of Business and Economics from Norwegian School of Management (BI) and University of Florida.

Roger Morberg

Mr. Roger Reino Morberg has served as Vice President Sales at Medistim ASA since June 2010. He is responsible for international sales. Roger has long experience from the healthcare sector, and is a trained medical professional and has experience from the healthcare industry. Roger has had various roles within Sales and Senior Management positions; from Marquette Electronics, GE Healthcare and Hewlett Packard. Before he joined Medistim he worked for Siemens Medical as Country Manager - Ultrasound.

Haege Krogh Wetterhus

Ms. Haege Johanne Krogh Wetterhus serves as Vice President Marketing at Medistim ASA. Haege J.K. Wetterhus has more than 20 years of experience working with diagnostic, analytical and biotech device companies. She started her career as a seller of analytical instrumentation, first for Hewlett-Packard (chromatography systems) and later for Boehringer Mannheim/Roche (clinical diagnostics). With her last employer, Invitrogen Dynal, she held a variety of leadership roles in strategic marketing, product development and business development in the area of life science and biotechnology - always with an international focus. Wetterhus is a business economist from BI, chemical engineer from the Technical University of Bergen and has a BSc Honor in molecular biology from the University of Glasgow, UK.

Anders Lillebo

Mr. Anders Lillebo has served as Vice President Manufacturing of Medistim ASA since March 2004. He is responsible for all activities at Medistim’s manufacturing site in Horten. Anders has worked over 20 years in the medical device industry. His last position was Production Manager at GE Vingmed Ultrasound in Horten, a manufacturer of ultrasound equipment. Anders brings experience in manufacturing of medical devices to Medistim. He manages several projects related to improvements in the supply chain, production flow and quality. Anders holds a B.Sc. degree in Engineering from Vestfold Engineering School.

Tone Veiteberg

Ms. Tone Ann Veiteberg serves as Vice President Regulatory Affairs & Quality Assurance at MEDISTIM ASA. Tone Veiteberg joined Medistim in 2013 and is responsible for quality assurance and regulatory compliance in the company. She has more than 25 years in Medical and Regulatory Affairs in the pharmaceutical and medical device industry, including Clavis Pharma, the Norwegian Association of Pharmaceutical Manufacturers, Leo Pharmaceuticals and Glaxo/GlaxoWellcome (now GlaxoSmithKline). Tone holds a M.Sc. in Pharmacy from the University of Oslo.

Erik Swensen

Mr. Erik Swensen has served as Vice President Research and Development of Medistim ASA since 2002. His previous experience includes Development Engineer at ABB, Norway (1996-2002), where he participated in the development of advanced process control systems. From 1999 his main focus was on developing ABB’s new control system for safety critical applications. Beside development work, Erik worked as Project Manager and Group Leader. Erik holds a M.Sc. degree in Engineering Cybernetics from the Norwegian Institute of Technology in Trondheim.

Siri Furst

Ms. Siri Furst has served as Member of the Board of Directors of Medistim ASA since April 25, 2013. She holds a degree in economics from NHH and is Managing Director of Considium Consulting Group from autumn 2011 and a Considium partner since 2005. She has had management positions in Hafslund AS, Hafslund Nycomed AS and DiaGenic ASA. She has worked within the areas strategy, business development, finance and investor relations. As a consultant she offers particular expertise in business development and strategy work, in addition to result assurance.

Tove Raanes

Ms. Tove Raanes has been Director of MEDISTIM ASA since April 23, 2014. She holds an MBA and works as a consultant for the investment companies Dyvi Invest AS (shareholder in Medistim) Varner Kapital AS, AS Vidsja and Nore-Invest AS. Tove Raanes has experience from strategy, finance and business development from several investment companies and management consulting from McKinsey & Company.

Lars Ronn

Mr. Lars Ronn serves as Member of the Board of Directors of Medistim ASA. Lars Ronn works as a consultant for Russell Reynolds Associates with focus on recruitment of executives within the med-tech area. He has previous experience as Executive Vice President, Sales & Marketing in Ambu A/S, a Danish med-tech company and as CEO in Origio A/S. He has a long and extensive experience from several positions in Maersk-Medical AS. Lars Ronn holds Bachelor of Science in Business, Language & Culture and has a Graduate Diploma in Int. Trade from CBS (Copenhagen Business School). He also has a Management Program from INSEAD. Lars Ronn is board member in Pressalit A/S.

Basic Compensation

Name Fiscal Year Total

Oyvin Broymer

250,000

Kari Krogstad

2,953,040

Bjorn Wiggen

150,000

Thomas Jakobsen

1,815,970

Mike Farbelow

1,888,860

Ole Robsrud

1,364,520

Roger Morberg

1,622,940

Haege Krogh Wetterhus

1,349,640

Anders Lillebo

1,229,280

Tone Veiteberg

1,124,420

Erik Swensen

1,235,330

Siri Furst

150,000

Tove Raanes

150,000

Lars Ronn

150,000
As Of  30 Dec 2015